Ha habido 50 transacciones internas recientes registradas para Disc Medicine, Inc. (IRON), incluyendo 15 compras y 35 ventas. El total de compras internas fue valorado en $19.3M y el total de ventas internas en $67.15M.
Internos destacados con actividad reciente incluyen Savage William Jacob, Franchi Jean M., Quisel John D. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — IRON
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-02 |
Savage William Jacob |
Chief Medical Officer |
Venta Informativa |
2,986 |
$66.41 |
$198.3K |
85,211 |
| 2026-02-25 |
Franchi Jean M. |
Chief Financial Officer |
Venta Informativa |
353 |
$69.06 |
$24.38K |
70,990 |
| 2026-02-18 |
Franchi Jean M. |
Chief Financial Officer |
Venta Informativa |
3,684 |
$65.89 |
$242.73K |
71,343 |
| 2026-02-17 |
Quisel John D |
Chief Executive Officer |
Venta Informativa |
13,264 |
$62.86 |
$833.78K |
226,064 |
| 2026-02-17 |
Stephenson Pamela |
Chief Commercial Officer |
Venta Informativa |
5,531 |
$62.86 |
$347.68K |
80,998 |
| 2026-02-17 |
Yu Jonathan Yen-wen |
Chief Operating Officer |
Venta Informativa |
3,231 |
$62.86 |
$203.1K |
54,324 |
| 2026-02-17 |
Khara Rahul |
Chief Legal Officer |
Venta Informativa |
2,853 |
$62.86 |
$179.34K |
52,173 |
| 2026-02-17 |
Savage William Jacob |
Chief Medical Officer |
Venta Informativa |
3,256 |
$62.86 |
$204.67K |
92,589 |
| 2026-02-17 |
Franchi Jean M. |
Chief Financial Officer |
Venta Informativa |
4,075 |
$62.86 |
$256.15K |
78,424 |
| 2026-02-10 |
Quisel John D |
Chief Executive Officer |
Concesión de RSU |
82,800 |
$74.75 |
$6.19M |
82,800 |
| 2026-02-10 |
Franchi Jean M. |
Chief Financial Officer |
Concesión de RSU |
25,500 |
$74.75 |
$1.91M |
25,500 |
| 2026-02-10 |
Stephenson Pamela |
Chief Commercial Officer |
Concesión de RSU |
25,500 |
$74.75 |
$1.91M |
25,500 |
| 2026-02-10 |
Yu Jonathan Yen-wen |
Chief Operating Officer |
Concesión de RSU |
25,500 |
$74.75 |
$1.91M |
25,500 |
| 2026-02-10 |
Khara Rahul |
Chief Legal Officer |
Concesión de RSU |
25,500 |
$74.75 |
$1.91M |
25,500 |
| 2026-02-10 |
Savage William Jacob |
Chief Medical Officer |
Concesión de RSU |
25,500 |
$74.75 |
$1.91M |
25,500 |
| 2026-01-20 |
Khara Rahul |
Chief Legal Officer |
Ejercicio de Opciones (Venta) |
1,000 |
$13.50 |
$13.5K |
21,270 |
| 2026-01-02 |
Khara Rahul |
Chief Legal Officer |
Ejercicio de Opciones (Venta) |
6,500 |
$13.50 |
$87.75K |
22,270 |
| 2025-12-22 |
Savage William Jacob |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
219 |
$9.86 |
$2.16K |
2,628 |
| 2025-12-19 |
Quisel John D |
Chief Executive Officer |
Ejercicio de Opciones |
12,300 |
$1.01 |
$12.42K |
184,128 |
| 2025-12-17 |
Bitterman Kevin |
Director |
Venta Informativa |
148 |
$91.47 |
$13.54K |
14,013 |
| 2025-12-16 |
Bitterman Kevin |
Director |
Venta Informativa |
14,359 |
$91.24 |
$1.31M |
14,161 |
| 2025-12-15 |
Bitterman Kevin |
Director |
Ejercicio de Opciones (Venta) |
7,000 |
$13.50 |
$94.5K |
- |
| 2025-12-15 |
Savage William Jacob |
Chief Medical Officer |
Venta Informativa |
300 |
$92.23 |
$27.67K |
75,702 |
| 2025-12-12 |
Bitterman Kevin |
Director |
Venta Informativa |
1,371 |
$93.80 |
$128.6K |
41,519 |
| 2025-12-11 |
Quisel John D |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
40,000 |
$9.86 |
$394.4K |
75,375 |
| 2025-11-11 |
Yu Jonathan Yen-wen |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
30,000 |
$2.65 |
$79.5K |
7,941 |
| 2025-10-22 |
Ai Dmi Llc |
10 Percent Owner |
Venta Informativa |
744,047 |
$80.47 |
$59.87M |
2,814,379 |
| 2025-10-17 |
Bitterman Kevin |
Director |
Venta Informativa |
450 |
$91.88 |
$41.35K |
385,549 |
| 2025-10-16 |
Bitterman Kevin |
Director |
Venta Informativa |
1,425 |
$77.11 |
$109.88K |
477,036 |
| 2025-10-15 |
Bitterman Kevin |
Director |
Venta Informativa |
2,618 |
$77.76 |
$203.58K |
478,461 |
| 2025-10-08 |
Bitterman Kevin |
Director |
Venta Informativa |
12,386 |
$69.31 |
$858.47K |
551,977 |
| 2025-10-07 |
Bitterman Kevin |
Director |
Venta Informativa |
6,661 |
$69.01 |
$459.68K |
572,582 |
| 2025-06-16 |
Franchi Jean M. |
Chief Financial Officer |
Venta Informativa |
2,000 |
$52.26 |
$104.52K |
67,530 |
| 2025-06-11 |
Gemayel Georges |
Director |
Concesión de RSU |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
Ratcliffe Liam |
Director |
Concesión de RSU |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
Bitterman Kevin |
Director |
Concesión de RSU |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
Chin Mark |
Director |
Concesión de RSU |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
White William Richard |
Director |
Concesión de RSU |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
Ashiya Mona |
Director |
Concesión de RSU |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-11 |
Nicholson Donald William |
Director |
Concesión de RSU |
10,000 |
$50.86 |
$508.6K |
10,000 |
| 2025-06-06 |
Savage William Jacob |
Chief Medical Officer |
Venta Informativa |
2,996 |
$50.00 |
$149.8K |
56,725 |
| 2025-05-20 |
Savage William Jacob |
Chief Medical Officer |
Venta Informativa |
6,677 |
$50.04 |
$334.13K |
59,721 |
| 2025-05-02 |
Savage William Jacob |
Chief Medical Officer |
Venta Informativa |
2,100 |
$50.17 |
$105.37K |
66,398 |
| 2025-04-07 |
Quisel John D |
Chief Executive Officer |
Ejercicio de Opciones |
7,000 |
$1.01 |
$7.07K |
161,828 |
| 2025-03-24 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
756 |
$54.11 |
$40.91K |
186,541 |
| 2025-03-24 |
Ashiya Mona |
Director |
Venta Informativa |
756 |
$54.11 |
$40.91K |
186,541 |
| 2025-03-21 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
1,320 |
$54.00 |
$71.28K |
187,297 |
| 2025-03-21 |
Ashiya Mona |
Director |
Venta Informativa |
1,320 |
$54.00 |
$71.28K |
187,297 |
| 2025-03-20 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
364 |
$54.01 |
$19.66K |
188,617 |
| 2025-03-20 |
Ashiya Mona |
Director |
Venta Informativa |
364 |
$54.01 |
$19.66K |
188,617 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
